Home › Funds › AustralianSuper Pty Ltd › BMY
AustralianSuper Pty Ltd position in BMY
BRISTOL-MYERS SQUIBB CO · Health Care
AustralianSuper Pty Ltd reported holding 3,310,439 shares of BMY (BRISTOL-MYERS SQUIBB CO) in its Q3 2026 13F filing — a position valued at US$206.6M, representing 0.85% of its reported portfolio and ranking #26 among its reported holdings. AustralianSuper Pty Ltd has disclosed BMY holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How AustralianSuper Pty Ltd's BMY position evolved
AustralianSuper Pty Ltd first disclosed a stake in BMY in Q4 2023 at 1,694,891 shares (US$87.0M). The position peaked in Q3 2026 at 3,310,439 shares, worth US$206.6M. Across 12 filings, AustralianSuper Pty Ltd increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,310,439 shares valued at US$206.6M — an increase of 877,085 shares quarter over quarter.. Notable position changes include a 82% increase in Q1 2024 (shares fell 23% over the following quarter), a 27% trim in Q3 2025 (shares rose 21% over the following quarter), a 36% increase in Q3 2026 (shares rose 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 1.69M | $86.96M | New |
| Q1 2024 | 3.08M | $163.30M | Add |
| Q2 2024 | 3.86M | $160.20M | Add |
| Q3 2024 | 3.34M | $172.86M | Reduce |
| Q4 2024 | 2.94M | $166.42M | Reduce |
| Q1 2025 | 2.73M | $166.44M | Reduce |
| Q2 2025 | 3.23M | $149.65M | Add |
| Q3 2025 | 2.36M | $106.49M | Reduce |
| Q4 2025 | 2.33M | $125.93M | Reduce |
| Q1 2026 | 2.13M | $128.90M | Reduce |
| Q2 2026 | 2.43M | $140.21M | Add |
| Q3 2026 | 3.31M | $206.57M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BMY and 13F data
BMY (BRISTOL-MYERS SQUIBB CO) is a Health Care company. 26 other funds we track also report a position in BMY — the largest reported positions include Charles Schwab Investment Management (US$3.89B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$3.89B), AQR Capital Management (US$1.58B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BMY
- Charles Schwab Investment Management 67.60M sh · $3.89B · Q2 2026
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 67.60M sh · $3.89B · Q2 2026
- AQR Capital Management 27.36M sh · $1.58B · Q2 2026
- AQR CAPITAL MANAGEMENT LLC 27.36M sh · $1.58B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 25.20M sh · $1.57B · Q3 2026
- Independent Franchise Partners LLP 21.54M sh · $1.34B · Q3 2026
- Pzena Investment Management 14.24M sh · $888.88M · Q3 2026
More on AustralianSuper Pty Ltd
FAQ
How long has AustralianSuper Pty Ltd held BMY?
AustralianSuper Pty Ltd has disclosed BMY holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is AustralianSuper Pty Ltd's current position in BMY?
As of Q3 2026, AustralianSuper Pty Ltd holds 3.31M shares of BMY (BRISTOL-MYERS SQUIBB CO), valued at $206.57M, representing 0.85% of its reported portfolio and ranking #26.
Has AustralianSuper Pty Ltd been buying or selling BMY?
In the latest 13F filing (Q3 2026), AustralianSuper Pty Ltd increased its position in BMY. The position peaked in Q3 2026 at 3.31M shares.
Which other funds hold BMY?
Other major institutional holders of BMY include Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, AQR Capital Management, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.